Last reviewed · How we verify
NCT04164680
Simultaneously PET/MRI in Prolonged DOC Patients
trial testing Multimodal Neuroimaging in Disorder of Consciousness in 24 participants. Completed in 1 January 2021.
1 January 2021
Quick facts
| Lead sponsor | Hangzhou Normal University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 24 |
| Start date | 1 January 2018 |
| Primary completion | 1 January 2021 |
| Estimated completion | 1 January 2021 |
| Sites | 1 location across China |
Drugs / interventions tested
- Multimodal Neuroimaging
Conditions studied
- Disorder of Consciousness — all drugs for Disorder of Consciousness →
- Minimally Conscious State — all drugs for Minimally Conscious State →
- FDG-PET — all drugs for FDG-PET →
- Rs-fMRI — all drugs for Rs-fMRI →
Sponsor
Hangzhou Normal University
Who can join
Adults 16 to 80, any sex, with Disorder of Consciousness or Minimally Conscious State. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Recently introduced hybrid PET/MR scanners provide the opportunity to measure simultaneously, and in direct spatial correspondence, both metabolic demand and functional activity of the brain, hence capturing complementary information on the brain's physiological state. Here we exploited PET/MR simultaneous imaging to explore the relationship between the metabolic information provided by resting-state fluorodeoxyglucose-PET (FDG-PET) and fMRI (rs-fMRI) in patients with disorders of consciousness.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04164680
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Disorder of Consciousness
Currently open trials in the same condition.
- NCT06896279 — Study on the Effectiveness and Safety of Temporal Interference Stimulation in Treating Patients With Severe Consciousnes · NA · recruiting
- NCT06515132 — Efficacy and Safety of Spinal Cord Stimulation in Patients With Spinal Cord Stimulation · NA · recruiting
- NCT06469983 — Robotic vs. Traditional Verticalization in Patients With Severe Acquired Brain Injury: a Randomized Controlled Trial · NA · recruiting
- NCT06527573 — Effects of rTMS With Different Stimulation Spots in Patients With Disorders of Consciousness · NA · recruiting
- NCT06635291 — Improving the Diagnostic Accuracy of Children with DoC (IDeAl DesiRE) · recruiting
Other Hangzhou Normal University trials
Trials by the same sponsor.
- NCT06536985 — Effect of an Oral Frailty Measures Intervention Programs in Institutionalized Elders · NA · not yet recruiting
- NCT06519695 — Exercise Intervention for Pre-frail Elderly · NA · active not recruiting
- NCT05496985 — Chinese Validation of the Simplified Evaluation of CONsciousness Disorders（SECONDs） · NA · completed
- NCT06014476 — Psychological Symptoms and Burden in Caregivers of Patients With Disorders of Consciousness · completed
- NCT06770348 — Investigating the Localization of Consciousness Through Patients with Disorders of Consciousness: Anterior Vs. Posterior · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04164680 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hangzhou Normal University
- Last refreshed: 8 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04164680.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing